Sri Gayathri Drugs Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1999.
1999 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Sri Gayathri Drugs Private Limited

Sri Gayathri Drugs Private Limited, a active private limited company, was established on 18 May 1999 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230TG1999PTC031720. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹1.25 Cr.

It upholds a compliant status. Employing 8 professional, Its leadership includes Kovvuri Rahul Reddy (Additional Director), Hemalatha Alla (Director), Sivaramakrishna Reddy Alla (Managing Director). Past directors included Venkata Reddy Kurre, Padmavathi Vegesna, Venkata Suryanarayana Raju Vegesna. It holds ₹6.69 Cr open charges and ₹1.66 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at H.No. 8-3-167/A/4, 2Nd Floor, Vikas Puri Colony, Near Ag Colony, S R Nagar Post,, Hyderabad, Telangana, 500038.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG1999PTC031720

  • Registration Number

    031720

  • Incorporation Date

    18 May 1999

  • Authorized Capital

    ₹2.50 Cr

  • Paid-Up Capital

    ₹1.25 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 Cr
  • Paid Up Capital ₹ 1.25 Cr
  • Company Age 26 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 6.69 Cr
  • Satisfied Charges ₹ 1.66 Cr
  • Revenue Growth **** -9.21%
  • Profit Growth **** -51.88%
  • Ebitda **** 8.44%
  • Net Worth 5.51%
  • Total Assets **** 17.77%
Company report

Sri Gayathri Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sri Gayathri Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sri Gayathri Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Kovvuri Rahul Reddy Additional Director 16 Feb 2024 Current
Hemalatha Alla Director 03 Jun 2011 Current
Sivaramakrishna Reddy Alla Managing Director 09 Oct 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 17 Oct 2011 Past
Pramod Abcsdd Director 09 Jul 2009 Past
Pramod Abcsdd Managing Director 09 Jul 2009 Past
Pramod Abcsdd Director 09 Jul 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sri Gayathri Drugs.

Sri Gayathri Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.21% decrease. The company also saw a substantial fall in profitability, with a 51.88% decrease in profit. The company's net worth moved up by a moderate rise of 5.51%.

Sri Gayathri Drugs revenue growth over time
Sri Gayathri Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -9.21%
*******
*******
*******
*******
Revenue from Operations
*******
 -8.92%
*******
*******
*******
*******
Total Assets
*******
 17.77%
*******
*******
*******
*******
Profit or Loss
*******
 -51.88%
*******
*******
*******
*******
Net Worth
*******
 5.51%
*******
*******
*******
*******
EBITDA
*******
 8.44%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sri Gayathri Drugs?

In 2023, Sri Gayathri Drugs had a promoter holding of 92.16% and a public holding of 7.84%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹66,900,000.00

Satisfied Charges

₹16,609,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 6.69 Cr
Latest Charge Details
Date Lender Amount Status
16 Dec 2021 Axis Bank Limited ₹5.00 M Open
30 Dec 2020 Axis Bank Limited ₹0.40 M Open
13 Oct 2006 Axis Bank Limited ₹6.15 Cr Open
26 Nov 2005 State Bank Of India ₹0.90 M Satisfied
10 Jan 2000 State Bank Of India ₹0.60 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sri Gayathri Drugs?

Sri Gayathri Drugs has a workforce of 8 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sri Gayathri Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Gayathri Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sri Gayathri Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Sri Gayathri Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Sri Gayathri Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Kovvuri Rahul Reddy was appointed as a Additional Director was appointed as a Additional Director on 16 Feb 2024 & has been associated with this company since 2 years 22 days . was recorded as a recent event.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 0.50 Cr with Charge ID 100539979 was registered on 16 Dec 2021. was documented.

  • Charges

    A charge with Axis Bank Limited of Rs. 6.15 Cr registered on 13 Oct 2006 with Charge ID 10023574 was modified on 18 Mar 2021. was recorded as a recent event.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 0.04 Cr with Charge ID 100410893 was registered on 30 Dec 2020. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sri Gayathri Drugs Private Limited?

The CIN of Sri Gayathri Drugs Private Limited is U24230TG1999PTC031720.

Where is Sri Gayathri Drugs Private Limited headquartered?

Sri Gayathri Drugs Private Limited is headquartered at H.No. 8-3-167/A/4, 2Nd Floor, Vikas Puri Colony, Near Ag Colony, S R Nagar Post,, Hyderabad, Telangana, 500038.

When was Sri Gayathri Drugs Private Limited incorporated?

Sri Gayathri Drugs Private Limited was incorporated on 18 May 1999.

Who are the current directors of Sri Gayathri Drugs Private Limited?

The current directors of Sri Gayathri Drugs Private Limited are

What is the primary industry of Sri Gayathri Drugs Private Limited?

The primary industry of Sri Gayathri Drugs Private Limited is Manufacturing.

Is Sri Gayathri Drugs Private Limited a listed company?

Sri Gayathri Drugs Private Limited is unlisted.

What is the capital structure of Sri Gayathri Drugs Private Limited?

The authorized capital of Sri Gayathri Drugs Private Limited is ₹2.50 Cr, and the paid-up capital is ₹1.25 Cr.

What is the compliance status of Sri Gayathri Drugs Private Limited?

The compliance status of Sri Gayathri Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available